MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$10,448K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prepaid expenses
Loss on disposal of property and...
Accounts payable
Others
Negative Cash Flow Breakdown
Accrued compensation and other a...
Operating lease liabilities
Change in fair value of continge...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-06-30
Stock-based compensation expense
593
Prepaid expenses
-2,825
Other current assets
-1,277
Operating lease liabilities
-110
Accounts payable
1,817
Loss on disposal of property and equipment
-2,564
Depreciation and amortization
301
Change in fair value of contingent consideration liability
-92
Accrued compensation and other accrued liabilities
-3,274
Net cash flows used in operating activities
-11,395
Proceeds from sale of property and equipment
947
Net cash flows provided by investing activities
947
Net decrease in cash, cash equivalents and restricted cash
-10,448
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sale of
property and equipment
$947K
Net cash flows
provided by investing...
$947K
Net decrease in
cash, cash...
-$10,448K
Canceled cashflow
$947K
Prepaid expenses
-$2,825K
Loss on disposal of
property and equipment
-$2,564K
Accounts payable
$1,817K
Other current assets
-$1,277K
Stock-based compensation
expense
$593K
Depreciation and
amortization
$301K
Net cash flows used
in operating...
-$11,395K
Canceled cashflow
$9,377K
something is missing
-$17,296K
Accrued compensation
and other accrued...
-$3,274K
Operating lease
liabilities
-$110K
Change in fair value of
contingent consideration...
-$92K
Buy us a coffee
Turnstone Biologics Corp. (TSBX)
Turnstone Biologics Corp. (TSBX)